{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:02:48Z","timestamp":1791039768080,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,1,13]],"date-time":"2012-01-13T00:00:00Z","timestamp":1326412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,1,13]],"date-time":"2012-01-13T00:00:00Z","timestamp":1326412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Italian Association for Cancer Research\u2010AIRC"},{"name":"Association for International Cancer Research (AICR\u2010UK","award":["11\u20100274 to L.T."],"award-info":[{"award-number":["11\u20100274 to L.T."]}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2012,3,1]]},"DOI":"10.1002\/emmm.201100205","type":"journal-article","created":{"date-parts":[[2012,1,13]],"date-time":"2012-01-13T11:36:28Z","timestamp":1326454588000},"page":"234-250","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["Tumour growth inhibition and anti\u2010metastatic activity of a mutated furin\u2010resistant Semaphorin 3E isoform"],"prefix":"10.1038","volume":"4","author":[{"given":"Andrea","family":"Casazza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boaz","family":"Kigel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Maione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Capparuccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofra","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Giraudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Mazzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gera","family":"Neufeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Tamagnone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,1,13]]},"reference":[{"key":"BFEMMM201100205_CR1","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1093\/emboj\/16.20.6077","volume":"16","author":"RH Adams","year":"1997","unstructured":"Adams RH, Lohrum M, Klostermann A, Betz H, P\u00fcschel AW (1997) The chemorepulsive activity of secreted semaphorins is regulated by furin\u2010dependent proteolytic processing. EMBO J 16: 6077\u20106086","journal-title":"EMBO J"},{"key":"BFEMMM201100205_CR2","first-page":"1399","volume":"52","author":"CJ Aslakson","year":"1992","unstructured":"Aslakson CJ, Miller FR (1992) Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 52: 1399\u20101405","journal-title":"Cancer Res"},{"key":"BFEMMM201100205_CR3","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1096\/fj.03-0957fje","volume":"18","author":"D Barberis","year":"2004","unstructured":"Barberis D, Artigiani S, Casazza A, Corso S, Giordano S, Love CA, Jones EY, Comoglio PM, Tamagnone L (2004) Plexin signaling hampers integrin\u2010based adhesion, leading to Rho\u2010kinase independent cell rounding, and inhibiting lamellipodia extension and cell motility. FASEB J 18: 592\u2010594","journal-title":"FASEB J"},{"key":"BFEMMM201100205_CR4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/mc.20134","volume":"44","author":"DE Bassi","year":"2005","unstructured":"Bassi DE, Fu J, Lopez de Cicco R, Klein\u2010Szanto AJ (2005) Proprotein convertases: \u201cmaster switches\u201d in the regulation of tumor growth and progression. Mol Carcinog 44: 151\u2010161","journal-title":"Mol Carcinog"},{"key":"BFEMMM201100205_CR5","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/35036374","volume":"2","author":"G Bergers","year":"2000","unstructured":"Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z et al (2000) Matrix metalloproteinase\u20109 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2: 737\u2010744","journal-title":"Nat Cell Biol"},{"key":"BFEMMM201100205_CR6","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1172\/JCI200317929","volume":"111","author":"G Bergers","year":"2003","unstructured":"Bergers G, Song S, Meyer\u2010Morse N, Bergsland E, Hanahan D (2003) Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest 111: 1287\u20101295","journal-title":"J Clin Invest"},{"key":"BFEMMM201100205_CR7","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1242\/jcs.030197","volume":"122","author":"L Capparuccia","year":"2009","unstructured":"Capparuccia L, Tamagnone L (2009) Semaphorin signaling in cancer cells and in cells of the tumor microenvironment\u2014two sides of a coin. J Cell Sci 122: 1723\u20101736","journal-title":"J Cell Sci"},{"key":"BFEMMM201100205_CR8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ccr.2005.09.005","volume":"8","author":"O Casanovas","year":"2005","unstructured":"Casanovas O, Hicklin DJ, Bergers G, Hanahan D (2005) Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late\u2010stage pancreatic islet tumors. Cancer Cell 8: 299\u2010309","journal-title":"Cancer Cell"},{"key":"BFEMMM201100205_CR9","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1172\/JCI42118","volume":"120","author":"A Casazza","year":"2010","unstructured":"Casazza A, Finisguerra V, Capparuccia L, Camperi A, Swiercz JM, Rizzolio S, Rolny C, Christensen C, Bertotti A, Sarotto I et al (2010) Sema3E\u2010Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice. J Clin Invest 120: 2684\u20102698","journal-title":"J Clin Invest"},{"key":"BFEMMM201100205_CR10","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1161\/ATVBAHA.110.211920","volume":"31","author":"A Casazza","year":"2011","unstructured":"Casazza A, Fu X, Johansson I, Capparuccia L, Andersson F, Giustacchini A, Squadrito ML, Venneri MA, Mazzone M, Larsson E et al (2011) Systemic and targeted delivery of Semaphorin 3A inhibits tumor angiogenesis and progression in mouse tumor models. Arterioscler Thromb Vasc Biol 31: 741\u2010749","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFEMMM201100205_CR11","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.neuron.2007.10.019","volume":"56","author":"S Chauvet","year":"2007","unstructured":"Chauvet S, Cohen S, Yoshida Y, Fekrane L, Livet J, Gayet O, Segu L, Buhot MC, Jessell TM, Henderson CE et al (2007) Gating of Sema3E\/PlexinD1 signaling by neuropilin\u20101 switches axonal repulsion to attraction during brain development. Neuron 56: 807\u2010822","journal-title":"Neuron"},{"key":"BFEMMM201100205_CR12","doi-asserted-by":"crossref","first-page":"6285","DOI":"10.1038\/onc.2008.304","volume":"27","author":"DA Cheresh","year":"2008","unstructured":"Cheresh DA, Stupack DG (2008) Regulation of angiogenesis: apoptotic cues from the ECM. Oncogene 27: 6285\u20106298","journal-title":"Oncogene"},{"key":"BFEMMM201100205_CR13","first-page":"1238","volume":"58","author":"CR Christensen","year":"1998","unstructured":"Christensen CR, Klingelh\u00f6fer J, Tarabykina S, Hulgaard EF, Kramerov D, Lukanidin E (1998) Transcription of a novel mouse semaphorin gene, M\u2010semaH, correlates with the metastatic ability of mouse tumor cell lines. Cancer Res 58: 1238\u20101244","journal-title":"Cancer Res"},{"key":"BFEMMM201100205_CR14","doi-asserted-by":"crossref","first-page":"6167","DOI":"10.1158\/0008-5472.CAN-04-4309","volume":"65","author":"C Christensen","year":"2005","unstructured":"Christensen C, Ambartsumian N, Gilestro G, Thomsen B, Comoglio P, Tamagnone L, Guldberg P, Lukanidin E (2005) Proteolytic processing converts the repelling signal Sema3E into an inducer of invasive growth and lung metastasis. Cancer Res 65: 6167\u20106177","journal-title":"Cancer Res"},{"key":"BFEMMM201100205_CR15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ccr.2009.01.021","volume":"15","author":"JM Ebos","year":"2009","unstructured":"Ebos JM, Lee CR, Cruz\u2010Munoz W, Bjarnason GA, Christensen JG, Kerbel RS (2009) Accelerated metastasis after short\u2010term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 15: 232\u2010239","journal-title":"Cancer Cell"},{"key":"BFEMMM201100205_CR16","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cell.2007.08.038","volume":"131","author":"C Fischer","year":"2007","unstructured":"Fischer C, Jonckx B, Mazzone M, Zacchigna S, Loges S, Pattarini L, Chorianopoulos E, Liesenborghs L, Koch M, De Mol M et al (2007) Anti\u2010PlGF inhibits growth of VEGF(R)\u2010inhibitor\u2010resistant tumors without affecting healthy vessels. Cell 131: 463\u2010475","journal-title":"Cell"},{"key":"BFEMMM201100205_CR17","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/embor.2008.139","volume":"9","author":"M Franco","year":"2008","unstructured":"Franco M, Tamagnone L (2008) Tyrosine phosphorylation in semaphorin signaling: shifting into overdrive. EMBO Rep 9: 865\u2010871","journal-title":"EMBO Rep"},{"key":"BFEMMM201100205_CR18","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1172\/JCI44900","volume":"121","author":"Y Fukushima","year":"2011","unstructured":"Fukushima Y, Okada M, Kataoka H, Hirashima M, Yoshida Y, Mann F, Gomi F, Nishida K, Nishikawa S, Uemura A (2011) Sema3E\u2010PlexinD1 signaling selectively suppresses disoriented angiogenesis in ischemic retinopathy in mice. J Clin Invest 121: 1974\u20101985","journal-title":"J Clin Invest"},{"key":"BFEMMM201100205_CR19","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/0092-8674(89)90945-8","volume":"58","author":"DS Grant","year":"1989","unstructured":"Grant DS, Tashiro K, Segui\u2010Real B, Yamada Y, Martin GR, Kleinman HK (1989) Two different laminin domains mediate the differentiation of human endothelial cells into capillary\u2010like structures in vitro. Cell 58: 933\u2010943","journal-title":"Cell"},{"key":"BFEMMM201100205_CR20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1126\/science.1105416","volume":"307","author":"C Gu","year":"2005","unstructured":"Gu C, Yoshida Y, Livet J, Reimert DV, Mann F, Merte J, Henderson CE, Jessell TM, Kolodkin AL, Ginty DD (2005) Semaphorin 3E and plexinD1 control vascular pattern independently of neuropilins. Science 307: 265\u2010268","journal-title":"Science"},{"key":"BFEMMM201100205_CR21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/315115a0","volume":"315","author":"D Hanahan","year":"1985","unstructured":"Hanahan D (1985) Heritable formation of pancreatic b\u2010cell tumours in transgenic mice expressing recombinant insulin\/simian virus 40 oncogenes. Nature 315: 115\u2010122","journal-title":"Nature"},{"key":"BFEMMM201100205_CR22","doi-asserted-by":"crossref","first-page":"e3287","DOI":"10.1371\/journal.pone.0003287","volume":"3","author":"B Kigel","year":"2008","unstructured":"Kigel B, Varshavsky A, Kessler O, Neufeld G (2008) Successful inhibition of tumor development by specific class\u20103 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells. PLoS One 3: e3287","journal-title":"PLoS One"},{"key":"BFEMMM201100205_CR23","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1101\/gad.2042011","volume":"25","author":"J Kim","year":"2011","unstructured":"Kim J, Oh WJ, Gaiano N, Yoshida Y, Gu C (2011) Semaphorin 3E\u2010Plexin\u2010D1 signaling regulates VEGF function in developmental angiogenesis via a feedback mechanism. Genes Dev 25: 1399\u20101411","journal-title":"Genes Dev"},{"key":"BFEMMM201100205_CR24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/ATVBAHA.110.215871","volume":"31","author":"S Kutschera","year":"2011","unstructured":"Kutschera S, Weber H, Weick A, De Smet F, Genove G, Takemoto M, Prahst C, Riedel M, Mikelis C, Baulande S et al (2011) Differential endothelial transcriptomics identifies semaphorin 3G as a vascular class 3 semaphorin. Arterioscler Thromb Vasc Biol 31: 151\u2010159","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFEMMM201100205_CR25","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/nprot.2009.96","volume":"4","author":"AM Laib","year":"2009","unstructured":"Laib AM, Bartol A, Alajati A, Korff T, Weber H, Augustin HG (2009) Spheroid\u2010based human endothelial cell microvessel formation in vivo. Nat Protoc 4: 1202\u20101215","journal-title":"Nat Protoc"},{"key":"BFEMMM201100205_CR26","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/sj.gt.3300947","volume":"6","author":"F Liu","year":"1999","unstructured":"Liu F, Song Y, Liu D (1999) Hydrodynamics\u2010based transfection in animals by systemic administration of plasmid DNA. Gene Ther 6: 1258\u20101266","journal-title":"Gene Ther"},{"key":"BFEMMM201100205_CR27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.mvr.2011.05.003","volume":"83","author":"Q Lu","year":"2012","unstructured":"Lu Q, Rounds S (2012) Focal adhesion kinase and endothelial cell apoptosis. Microvasc Res 83: 56\u201063","journal-title":"Microvasc Res"},{"key":"BFEMMM201100205_CR28","first-page":"3356","volume":"119","author":"F Maione","year":"2009","unstructured":"Maione F, Molla F, Meda C, Latini R, Zentilin L, Giacca M, Seano G, Serini G, Bussolino F, Giraudo E (2009) Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models. J Clin Invest 119: 3356\u20103372","journal-title":"J Clin Invest"},{"key":"BFEMMM201100205_CR29","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/nrc2404","volume":"8","author":"G Neufeld","year":"2008","unstructured":"Neufeld G, Kessler O (2008) The semaphorins: versatile regulators of tumour progression and tumour angiogenesis. Nat Rev Cancer 8: 632\u2010645","journal-title":"Nat Rev Cancer"},{"key":"BFEMMM201100205_CR30","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1126\/science.1097545","volume":"305","author":"I Oinuma","year":"2004","unstructured":"Oinuma I, Ishikawa Y, Katoh H, Negishi M (2004) The Semaphorin 4D receptor Plexin\u2010B1 is a GTPase activating protein for R\u2010Ras. Science 305: 862\u2010865","journal-title":"Science"},{"key":"BFEMMM201100205_CR31","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ccr.2009.01.027","volume":"15","author":"M P\u00e0ez\u2010Ribes","year":"2009","unstructured":"P\u00e0ez\u2010Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, Vi\u00f1als F, Inoue M, Bergers G, Hanahan D, Casanovas O (2009) Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15: 220\u2010231","journal-title":"Cancer Cell"},{"key":"BFEMMM201100205_CR32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.drup.2009.03.002","volume":"12","author":"A Rapisarda","year":"2009","unstructured":"Rapisarda A, Melillo G (2009) Role of the hypoxic tumor microenvironment in the resistance to anti\u2010angiogenic therapies. Drug Resist Updat 12: 74\u201080","journal-title":"Drug Resist Updat"},{"key":"BFEMMM201100205_CR33","doi-asserted-by":"crossref","first-page":"8317","DOI":"10.1158\/0008-5472.CAN-04-4366","volume":"65","author":"I Roodink","year":"2005","unstructured":"Roodink I, Raats J, van der Zwaag B, Verrijp K, Kusters B, van Bokhoven H, Linkels M, de Waal RM, Leenders WP (2005) Plexin D1 expression is induced on tumor vasculature and tumor cells: a novel target for diagnosis and therapy? Cancer Res 65: 8317\u20108323","journal-title":"Cancer Res"},{"key":"BFEMMM201100205_CR34","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1471-2407-9-297","volume":"9","author":"I Roodink","year":"2009","unstructured":"Roodink I, Verrijp K, Raats J, Leenders WP (2009) Plexin D1 is ubiquitously expressed on tumor vessels and tumor cells in solid malignancies. BMC Cancer 9: 297","journal-title":"BMC Cancer"},{"key":"BFEMMM201100205_CR35","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1128\/MCB.01652-09","volume":"30","author":"A Sakurai","year":"2010","unstructured":"Sakurai A, Gavard J, Annas\u2010Linhares Y, Basile JR, Amornphimoltham P, Palmby TR, Yagi H, Zhang F, Randazzo PA, Li X et al (2010) Semaphorin 3E initiates antiangiogenic signaling through plexin D1 by regulating Arf6 and R\u2010Ras. Mol Cell Biol 30: 3086\u2010398","journal-title":"Mol Cell Biol"},{"key":"BFEMMM201100205_CR36","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/nbt1323","volume":"25","author":"F Shojaei","year":"2007","unstructured":"Shojaei F, Wu X, Malik AK, Zhong C, Baldwin ME, Schanz S, Fuh G, Gerber HP, Ferrara N (2007) Tumor refractoriness to anti\u2010VEGF treatment is mediated by CD11b+Gr1+ myeloid cells. Nat Biotechnol 25: 911\u2010920","journal-title":"Nat Biotechnol"},{"key":"BFEMMM201100205_CR37","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1096\/fj.06-6277com","volume":"21","author":"N Shraga\u2010Heled","year":"2007","unstructured":"Shraga\u2010Heled N, Kessler O, Prahst C, Kroll J, Augustin H, Neufeld G (2007) Neuropilin\u20101 and neuropilin\u20102 enhance VEGF121 stimulated signal transduction by the VEGFR\u20102 receptor. FASEB J 21: 915\u2010926","journal-title":"FASEB J"},{"key":"BFEMMM201100205_CR38","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cell.2010.02.039","volume":"141","author":"S Van de Veire","year":"2010","unstructured":"Van de Veire S, Stalmans I, Heindryckx F, Oura H, Tijeras\u2010Raballand A, Schmidt T, Loges S, Albrecht I, Jonckx B, Vinckier S et al (2010) Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease. Cell 141: 178\u2010190","journal-title":"Cell"},{"key":"BFEMMM201100205_CR39","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.1158\/0008-5472.CAN-07-5408","volume":"68","author":"A Varshavsky","year":"2008","unstructured":"Varshavsky A, Kessler O, Abramovitch S, Kigel B, Zaffryar S, Akiri G, Neufeld G (2008) Semaphorin\u20103B is an angiogenesis inhibitor that is inactivated by furin\u2010like pro\u2010protein convertases. Cancer Res 68: 6922\u20106931","journal-title":"Cancer Res"},{"key":"BFEMMM201100205_CR40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.tibs.2008.01.006","volume":"33","author":"Y Zhou","year":"2008","unstructured":"Zhou Y, Gunput RA, Pasterkamp RJ (2008) Semaphorin signaling: progress made and promises ahead. Trends Biochem Sci 33: 161\u2010170","journal-title":"Trends Biochem Sci"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1002\/emmm.201100205.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/emmm.201100205","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1002\/emmm.201100205\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.1002\/emmm.201100205","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1002\/emmm.201100205.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:01:26Z","timestamp":1779084086000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1002\/emmm.201100205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,13]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3,1]]}},"alternative-id":["BFEMMM201100205"],"URL":"https:\/\/doi.org\/10.1002\/emmm.201100205","relation":{},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,13]]},"assertion":[{"value":"19 July 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}